Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.8373
-0.0033 (-0.39%)
At close: Nov 12, 2025, 4:00 PM EST
0.8271
-0.0102 (-1.22%)
After-hours: Nov 12, 2025, 7:15 PM EST
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $10.72 million as of November 12, 2025.
Market Cap
10.72M
Enterprise Value
12.48M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since August 15, 2025, Propanc Biopharma's market cap has decreased from $36.20M to $10.72M, a decrease of -70.38%. That is a compound annual growth rate of -99.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 13.20M | -7.69% |
| Nov 6, 2025 | 14.30M | -5.30% |
| Nov 5, 2025 | 15.10M | 11.03% |
| Nov 4, 2025 | 13.60M | -6.21% |
| Nov 3, 2025 | 14.50M | -8.81% |
| Oct 31, 2025 | 15.90M | - |
| Oct 30, 2025 | 15.90M | -5.36% |
| Oct 29, 2025 | 16.80M | -7.69% |
| Oct 28, 2025 | 18.20M | -4.21% |
| Oct 27, 2025 | 19.00M | -2.56% |
| Oct 24, 2025 | 19.50M | 2.63% |
| Oct 23, 2025 | 19.00M | 6.74% |
| Oct 22, 2025 | 17.80M | -12.75% |
| Oct 21, 2025 | 20.40M | 0.99% |
| Oct 20, 2025 | 20.20M | - |
| Oct 17, 2025 | 20.20M | - |
| Oct 16, 2025 | 20.20M | -9.01% |
| Oct 15, 2025 | 22.20M | -2.63% |
| Oct 14, 2025 | 22.80M | -2.56% |
| Oct 13, 2025 | 23.40M | 5.41% |
| Oct 10, 2025 | 22.20M | -7.88% |
| Oct 9, 2025 | 24.10M | -1.63% |
| Oct 8, 2025 | 24.50M | -2.39% |
| Oct 7, 2025 | 25.10M | -1.18% |
| Oct 6, 2025 | 25.40M | 11.89% |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 885.19B |
| Johnson & Johnson | 466.99B |
| AbbVie | 397.96B |
| UnitedHealth Group | 296.62B |
| AstraZeneca | 275.02B |
| Novartis AG | 249.68B |
| Merck & Co. | 225.74B |
| Abbott Laboratories | 220.84B |